Abstract
Esophageal cancer is the sixth most common cancer in the world [1]. There has been a divergence of histological cell type between the East and West. In western countries, adenocarcinoma has increased dramatically in incidence in the past 30 years, closely related to rising prevalence of obesity, gastroesophageal reflux disease, and Barrett’s esophagus. In Asia, esophageal squamous cell carcinoma (ESCC) remains the predominant cell type; more than 80 % of esophageal cancer is squamous cell in origin. There has not been a convincing rise in incidence of true adenocarcinoma of the esophagus (Siewert type I) in Asia. In Hong Kong, ESCC accounts for more than 90 % of all esophageal cancers. In 2010, the Cancer Registry of Hong Kong identified esophageal cancer as the eighth leading cause of cancer deaths. The overall 5-year survival rate was disappointing at around 20 % only [2].
There has been advancement of technology in diagnosis, staging, and treatment of this highly lethal disease in the last few decades. In Hong Kong, more than 70 % of esophageal cancer patients are diagnosed at stage III/IV. Diagnosis at an earlier stage can improve the outcome and prognosis. Accurate staging allows optimal stage-directed therapeutic strategy. Multimodality treatment methods such as neoadjuvant chemotherapy or chemoradiation with surgery have gained popularity and outcomes have improved compared with surgical resection alone. The authors will summarize the treatment strategies and experience at The University of Hong Kong.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Hospital Authority (2012) Hong Kong Cancer Registry. http://www3.ha.org.hk/cancereg. Accessed 20 Aug 2014
Cheung HC, Siu KF, Wong J (1988) A comparison of flexible and rigid endoscopy in evaluating esophageal cancer patients for surgery. World J Surg 12(1):117–122
Fok M, Cheng SW, Wong J (1992) Endosonography in patient selection for surgical treatment of esophageal carcinoma. World J Surg 16(6):1098–1103, discussion 1103
Choi TK, Siu KF, Lam KH, Wong J (1984) Bronchoscopy and carcinoma of the esophagus I. Findings of bronchoscopy in carcinoma of the esophagus. Am J Surg 147(6):757–759
Choi TK, Siu KF, Lam KH, Wong J (1984) Bronchoscopy and carcinoma of the esophagus II. Carcinoma of the esophagus with tracheobronchial involvement. Am J Surg 147(6):760–762
Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR (2008) Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 14(10):1479–1490
Lowe VJ, Booya F, Fletcher JG et al (2005) Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 7(6):422–430
Dittler HJ, Bollschweiler E, Siewert JR (1991) What is the value of endosonography in the preoperative staging of esophageal carcinoma? Dtsch Med Wochenschr 116(15):561–566
Law S, Wong KH, Tong DK, Wong J (2007) Standardized uptake value (SUV) in PET/CT for oesophageal cancer correlates with pathological stage and predicts R-category of resection. Gut 56(suppl 3):A223
Lagarde SM, Maris AK, de Castro SM, Busch OR, Obertop H, van Lanschot JJ (2007) Evaluation of O-POSSUM in predicting in-hospital mortality after resection for oesophageal cancer. Br J Surg 94(12):1521–1526
Law SY, Fok M, Wong J (1994) Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg 18(3):339–346
Law S, Wong KH, Kwok KF, Chu KM, Wong J (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240(5):791–800
Kuwano H, Nishimura Y, Ohtsu A et al (2008) Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2007 edition: part I edited by the Japan Esophageal Society. Esophagus 5:61–73
Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27(30):5062–5067
Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359(9319):1727–1733
Ando N, Kato H, Igaki H et al (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19(1):68–74
Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326(24):1593–1598
al-Sarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15(1):277–284
Cooper JS, Guo MD, Herskovic A, Radiation Therapy Oncology Group et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Jama 281(17):1623–1627
van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084
Fok M, Sham JS, Choy D, Cheng SW, Wong J (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113(2):138–147
Chen J, Zhu J, Pan J et al (2010) Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus. Ann Thorac Surg 90(2):435–442
Xiao ZF, Yang ZY, Liang J et al (2003) Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75(2):331–336
Law S, Fok M, Chow S, Chu KM, Wong J (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114(2):210–217
Lam KY, Law S, Ma LT, Ong SK, Wong J (1997) Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness? Eur J Cancer 33(8):1221–1225
Tong DK, Law S, Kwong DL, Chan KW, Lam AK, Wong KH (2010) Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol 17(8):2184–2192
Law S, Kwong DL, Kwok KF et al (2003) Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 238(3):339–347, discussion 347–338
Tong DK, Law S, Kwong DL, Chan SY, Wong KH (2011) What is the appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer. World J Surg 35(Suppl 1):S172 (0450)
Law S, Kwong DL, Wong KH, Kwok KF, Wong J (2006) The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J Gastrointest Surg 10(9):1301–1311
Weber WA, Ott K, Becker K et al (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19(12):3058–3065
Lordick F, Ott K, Krause BJ et al (2007) PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8(9):797–805
Ong GB, Lee TC (1960) Pharyngogastric anastomosis after oesophago-pharyngectomy for carcinoma of the hypopharynx and cervical oesophagus. Br J Surg 48:193–200
Law SY, Fok M, Wei WI et al (2000) Thoracoscopic esophageal mobilization for pharyngolaryngoesophagectomy. Ann Thorac Surg 70(2):418–422
Cense HA, Law S, Wei W et al (2007) Pharyngolaryngoesophagectomy using the thoracoscopic approach. Surg Endosc 21(6):879–884
Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH (2011) Current management of cervical esophageal cancer. World J Surg 35(3):600–607
Wei WI, Lam LK, Yuen PW, Wong J (1998) Current status of pharyngolaryngo-esophagectomy and pharyngogastric anastomosis. Head Neck 20(3):240–244
Lam KH, Wong J, Lim ST, Ong GB (1981) Pharyngogastric anastomosis following pharyngolaryngoesophagectomy. Analysis of 157 cases. World J Surg 5(4):509–516
Spiro RH, Bains MS, Shah JP, Strong EW (1991) Gastric transposition for head and neck cancer: a critical update. Am J Surg 162(4):348–352
Le Quesne LP, Ranger D (1966) Pharyngolaryngectomy, with immediate pharyngogastric anastomosis. Br J Surg 53(2):105–109
Wei WI, Lam LK, Yuen PW, Kwong D, Chan KW (1998) Mucosal changes of the free jejunal graft in response to radiotherapy. Am J Surg 175(1):44–46
Chan JY, Liu LH, Wei WI (2013) Early prediction of anastomotic leakage after free jejunal flap reconstruction of circumferential pharyngeal defects. J Plast Reconstr Aesthet Surg 66(3):376–381
Chu KM, Law SY, Fok M, Wong J (1997) A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 174(3):320–324
Law S, Fok M, Chu KM, Wong J (1997) Thoracoscopic esophagectomy for esophageal cancer. Surgery 122(1):8–14
Law S, Wong J (2002) Use of minimally invasive oesophagectomy for cancer of the oesophagus. Lancet Oncol 3(4):215–222
Biere SS, van Berge Henegouwen MI, Maas KW et al (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379(9829):1887–1892
Law S (2012) Is minimally invasive preferable to open oesophagectomy? Lancet 379(9829):1856–1858
Law S, Arcilla C, Chu KM, Wong J (1998) The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg 176(3):286–290
Law SY, Fok M, Wong J (1996) Pattern of recurrence after oesophageal resection for cancer: clinical implications. Br J Surg 83(1):107–111
Tong DK, Kwong DL, Law S, Wong KH, Wong J (2008) Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease. J Gastrointest Surg 12(10):1638–1645, discussion 1645
Fok M, Cheng SW, Wong J (1991) Pyloroplasty versus no drainage in gastric replacement of the esophagus. Am J Surg 162(5):447–452
Lee YM, Law S, Chu KM, Wong J (2000) Pyloroplasty in gastric replacement of the esophagus after esophagectomy: one-layer or two-layer technique? Dis Esophagus 13(3):203–206
Law S, Cheung MC, Fok M, Chu KM, Wong J (1997) Pyloroplasty and pyloromyotomy in gastric replacement of the esophagus after esophagectomy: a randomized controlled trial. J Am Coll Surg 184(6):630–636
Davis PA, Law S, Wong J (2003) Colonic interposition after esophagectomy for cancer. Arch Surg 138(3):303–308
Tong DK, Law S, Chan SY (2012) Operative outcomes of colonic interposition in the treatment of esophageal cancer: a three decades experience. Gastroenterology 142(5):S-1075, Supplement 1
Gawad KA, Hosch SB, Bumann D et al (1999) How important is the route of reconstruction after esophagectomy: a prospective randomized study. Am J Gastroenterol 94(6):1490–1496
Wong AC, Law S, Wong J (2003) Influence of the route of reconstruction on morbidity, mortality and local recurrence after esophagectomy for cancer. Dig Surg 20(3):209–214
Tong DK, Law S (2013) Reconstruction after pharyngolaryngectomy and esophagectomy: challenges and outcomes. Jpn Bronco Esophagol Soc 64(2):65–70
Biere SS, Maas KW, Cuesta MA, van der Peet DL (2011) Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg 28(1):29–35
Law S, Fok M, Chu KM, Wong J (1997) Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial. Ann Surg 226(2):169–173
Whooley BP, Law S, Alexandrou A, Murthy SC, Wong J (2001) Critical appraisal of the significance of intrathoracic anastomotic leakage after esophagectomy for cancer. Am J Surg 181(3):198–203
Lorentz T, Fok M, Wong J (1989) Anastomotic leakage after resection and bypass for esophageal cancer: lessons learned from the past. World J Surg 13(4):472–477
Murthy SC, Law S, Whooley BP, Alexandrou A, Chu KM, Wong J (2003) Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 126(4):1162–1167
Tsui SL, Law S, Fok M et al (1997) Postoperative analgesia reduces mortality and morbidity after esophagectomy. Am J Surg 173(6):472–478
Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J (2001) Analysis of reduced death and complication rates after esophageal resection. Ann Surg 233(3):338–344
Whooley BP, Law S, Murthy SC, Alexandrou A, Chu KM, Wong J (2002) The Kirschner operation in unresectable esophageal cancer: current application. Arch Surg 137(11):1228–1232
Wong J, Lam KH, Wei WI, Ong GB (1981) Results of the Kirschner operation. World J Surg 5(4):547–552
Tong DK, Law S, Wong KH (2010) The use of self-expanding metallic stents (SEMS) is effective in symptom palliation from recurrent tumor after esophagogastrectomy for cancer. Dis Esophagus 23(8):660–665
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Japan
About this chapter
Cite this chapter
Tong, D., Law, S. (2015). Hong Kong Experience. In: Ando, N. (eds) Esophageal Squamous Cell Carcinoma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54977-2_15
Download citation
DOI: https://doi.org/10.1007/978-4-431-54977-2_15
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54976-5
Online ISBN: 978-4-431-54977-2
eBook Packages: MedicineMedicine (R0)